Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Immune related proteins and tumor infiltratingCD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome

Title: Immune related proteins and tumor infiltratingCD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome
Authors: Landin, David; Ahrlund-Richter, Andreas; Mirzaie, Leila; Mints, Michael; Nasman, Anders; Kolev, Aeneas; Marklund, Linda; Dalianis, Tina; Munck-Wikland, Eva; Ramqvist, Torbjorn
Publisher Information: Umeå universitet, Urologi och andrologi; Departement of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
Publication Year: 2020
Collection: Umeå University: Publications (DiVA)
Subject Terms: CD8-positive lymphocytes; clinical outcome; human papillomavirus; hypopharyngeal cancer; protein expression; Cancer and Oncology; Cancer och onkologi
Description: Background: Hypopharyngeal cancer (HPSCC) shows a poor clinical outcome, while HPSCC, caused by human papillomavirus (HPV), presents a better outcome. Here, HPCC, immune proteins, and tumor infiltrating CD8+ lymphocytes (CD8+ TILs) were evaluated in relation to HPV and outcome. Methods: Fresh frozen tissue from four HPV-positive HPSCC, 39 HPV-negative HPSCC, and normal samples were analyzed for protein expression by the Proseek immuno-oncology immunoassay. CD8+ TIL numbers evaluated by immunohistochemistry on 144 formalin-fixed biopsies were analyzed in relation to clinical outcome. Results: Proteins differing between HPV-positive and negative HPSCC included CD8A, PD-L1, Fas ligand, and chemokines. High CD8+ TIL numbers were correlated to improve clinical outcome in HPV-negative HPSCC. Conclusions: High expression of immune proteins in HPV-positive HPSCC may explain the better clinical outcome. CD8+ TILs are of relevance for outcome of HPV-negative HPSCC, while tumors with high immune activity but poor patient survival suggest a role for immune therapy.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISBN: 978-0-00-544628-7; 0-00-544628-7
Relation: Head and Neck, 1043-3074, 2020, 42:11, s. 3206-3217; PMID 32613643; ISI:000544628700001
DOI: 10.1002/hed.26364
Availability: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-173590; https://doi.org/10.1002/hed.26364
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.49BD2E47
Database: BASE